Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Analytical Development
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(58)
1 / 3
LNP Strategy
Building Better RNA Medicines Through Smarter LNP Formulation Strategy
Aula Al Muslim, Ph.D.
Recipharm Advanced Bio
PAO-06-26-CL-03
Jun 22, 2026
Oligo Analytics
Impurities, Sequence Fidelity, and Structural Variants in Nucleic Acid Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-23
May 26, 2026
Pathfinder
In Vitro vs. In Vivo Potency Assays: Which Approach Is Best for Biopharmaceutical Product Characterization?
Pharma's Almanac
PAO-26-PF-07
May 15, 2026
PAT
Real-Time Insight in Biologic Manufacturing: Why PAT Matters for Commercial Scale-Up
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-26-PA-11
Apr 16, 2026
PAT
From Analytical Visibility to Real-Time Control in Biologics Purification
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-26-PA-10
Apr 15, 2026
ADCs
Accelerating ADC Analytical Method Development Through Platform Innovation
Jaeook Kim, Ph.D.
Samsung Biologics
PAO-03-26-CL-06
Mar 23, 2026
Biosimilars
Biosimilars at a Crossroads: Will the FDA’s New Framework Deliver Competition?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-25-NI-04
Nov 14, 2025
Mass Spectrometry
Growing Importance of Mass Spectrometry from Drug Discovery through Commercialization and Life Cycle Management
Stefan Lehnert, Ph.D.; Carsten Kroeger, Dr. rer. nat.
Coriolis Pharma
PAO-11-25-CL-04
Nov 12, 2025
APM
Raising the Bar in Analytical Excellence: Samsung Biologics’ Approach to Assay Performance Monitoring
Jinwon Choi, Ph.D.; Siyoong Seo; Masany Jung; Soeun Jang
Samsung Biologics
PAO-10-25-CL-09
Oct 28, 2025
Analytical
Compressing Analytical Timelines Without Cutting Corners
George Wei
Experic
PAO-06-25-CL-10
Jul 16, 2025
Formulation
Formulation and Analytics Platforms Transforming Drug Product Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-06
Jul 16, 2025
Automation
Engineering the Future of Biopharmaceutical Manufacturing with Intelligent Automation and Digitalization
Eckelmann Group
PAO-04-25-CL-08
Apr 28, 2025
Analytical
Leveraging Advanced GMP Release and Stability Testing Methods to Accelerate New Drug Development
Gerhard Sax, Dr. rer. nat.; Carsten Kroeger, Dr. rer. nat.
Coriolis Pharma
PAO-04-25-CL-03
Apr 15, 2025
Fermentation
Achieving Scalable and Sustainable Precision Fermentation Using Process Analytical Technology
Charlotte Hughes, Ph.D.
Hamilton Company
PAO-02-25-CL-18
Feb 27, 2025
RNA
Optimized Residual dsRNA Detection for mRNA Therapeutics
Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang; Eunseo (Ency) Lee, Ph.D
Samsung Biologics
PAO-09-24-CL-07
Sep 30, 2024
Bioassays
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Anke Hartung, Ph.D.,
Tanvex CDMO
PAO-09-24-CL-09
Sep 30, 2024
Sequence Variants
Accelerating Protein Sequence Variant Analysis
Yunjeong Heo; Kyoungmin Lee; Jongbae Park
Samsung Biologics
PAO-08-24-CL-08
Aug 13, 2024
Analytical Method Development
Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
Xuemei Han, Ph.D.
Tanvex CDMO
PAO-03-24-CL-09
Mar 13, 2024
Chromatography
Navigating HPLC Method Development: Tips for Success
Ransom Jones
Mikart
PAO-12-23-CL-09
Jan 17, 2024
Failing Fast
Maximizing Resources and Potential for Success by Failing Fast
Nazar Elkarim, Ph.D.
Mikart
PAO-10-23-CL-02
Oct 23, 2023
1 / 3